Pajjiż: New Zealand
Lingwa: Ingliż
Sors: Medsafe (Medicines Safety Authority)
Conjugated estrogens 0.625mg (15mg as a dessication with lactose. Includes 3% overage.); ; Medroxyprogesterone acetate 5mg (Includes 4% overage); Conjugated estrogens 0.625mg (15mg as a dessication with lactose. Includes 3% overage.); Medroxyprogesterone acetate 5mg (Includes 4% overage)
Pfizer New Zealand Limited
Conjugated estrogens 0.625 mg (15mg as a dessication with lactose. Includes 3% overage.)
Tablet
Active: Conjugated estrogens 0.625mg (15mg as a dessication with lactose. Includes 3% overage.) Medroxyprogesterone acetate 5mg (Includes 4% overage) Excipient: Calcium sulfate Carnauba wax Glyceryl mono-oleate Iron oxide red Lactose monohydrate Macrogols Magnesium stearate Methylcellulose Microcrystalline cellulose Opacode black S-8-27741 Povidone Shellac Stearic acid Sucrose Titanium dioxide Active: Conjugated estrogens 0.625mg (15mg as a dessication with lactose. Includes 3% overage.) Medroxyprogesterone acetate 5mg (Includes 4% overage) Excipient: Calcium sulfate Carnauba wax Glyceryl mono-oleate Indigo carmine Lactose monohydrate Macrogols Magnesium stearate Methylcellulose Microcrystalline cellulose Opacode black S-8-27741 Povidone Shellac Stearic acid Sucrose Titanium dioxide
Calendar pack, 28 tablets
Prescription
Prescription
Pfizer Global Manufacturing
Package - Contents - Shelf Life: Calendar pack, - 28 tablets - 36 months from date of manufacture stored at or below 25°C - Calendar pack, - 84 tablets - 36 months from date of manufacture stored at or below 25°C
1995-06-14
PREMIA CONTINUOUS 1 PREMIA ® 2.5 CONTINUOUS & PREMIA 5 CONTINUOUS _Conjugated Oestrogens and Medroxyprogesterone acetate Tablets_ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some of the common questions about Premia Continuous Tablets. It does not contain all of the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking Premia Continuous against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. Your doctor and pharmacist have more information. KEEP THIS LEAFLET WITH THE MEDICINE. YOU MAY NEED TO READ IT AGAIN. WHAT PREMIA CONTINUOUS IS USED FOR Premia Continuous is a type of treatment called hormone replacement therapy (HRT) and contains the hormones conjugated oestrogens and medroxyprogesterone acetate (MPA). Premia Continuous helps to relieve the discomfort many women feel during and after menopause, including symptoms such as "hot flushes", sweating and vaginal dryness. It also helps to prevent thinning of the bones (osteoporosis), which can cause fractures, in some women. Premia Continuous is used by women who still have a uterus (womb). If your doctor thinks you will need to take HRT for a long time, including for the prevention of osteoporosis, your doctor will have considered the benefits and risks of other treatments before prescribing Premia Continuous for you. _HOW IT WORKS_ Menopause occurs naturally in women usually between the ages of 45 and 55. During menopause, your body produces less oestrogen than it did beforehand. This can cause symptoms such as "hot flushes", a sudden, intense feeling of heat and sweating throughout the body. Some women also have problems with dryness of the vagina causing discomfort during or after sexual intercourse. Some women develop osteoporosis during or after menopause. This is a thinning of the bones that makes them weaker and more likely to br Aqra d-dokument sħiħ
DATA SHEET PREMIA 2. 5 CONTINUOUS AND PREMIA 5 CONTINUOUS Conjugated estrogens 0.625 mg and medroxyprogesterone acetate 2.5 mg tablets. Conjugated estrogens 0.625 mg and medroxyprogesterone acetate 5 mg tablets. NAME OF THE MEDICINE PREMIA 2.5 Continuous 0.625 mg conjugated estrogens and 2.5 mg medroxyprogesterone acetate tablets. PREMIA 5 Continuous 0.625 mg conjugated estrogens and 5 mg medroxyprogesterone acetate as tablets. Conjugated estrogens (CE) are a mixture of natural estrogens of equine origin. Medroxyprogesterone acetate (MPA) is a progestogen and a derivative of progesterone. The chemical name is 6α-methyl-3,20-dioxopregn-4-en-17α-yl acetate and the structural formula is: The molecular formula is C 24 H 34 O 4 and molecular weight is 386.53. The CAS No. is 71-58-9. DESCRIPTION PREMIA 2.5 Continuous and PREMIA 5 Continuous combination tablets are hormone replacement therapy packs. Each PREMIA Continuous tablet has an inner PREMARIN core and an outer coat containing micronised MPA. PREMIA 2.5 Continuous tablets contain 0.625 mg CE and 2.5 mg MPA as active ingredients. PREMIA 5 Continuous tablets contain 0.625 mg CE and 5 mg MPA as active ingredients. Each tablet also contains lactose monohydrate, methylcellulose, magnesium stearate, shellac, macrogol 20000, glyceryl mono-oleate, microcrystalline cellulose, calcium phosphate, calcium sulfate, sucrose, titanium dioxide, carnauba wax and black ink. PREMIA 2.5 Continuous tablets are peach in colour and PREMIA 5 Continuous tablets are blue. PREMIA 2.5 Continuous tablets contain iron oxide red as the colouring agent while PREMIA 5 Continuous tablets contain indigo carmine as the colouring agent. CE are composed principally of the sodium salts of water soluble sulfate esters of estrone, equilin and 17α-dihydroequilin, together with smaller amounts of 17α-estradiol, equilenin, 17α- pfdpreit110716 supersedes pfdpreit10611 Page 1 of 19 dihydroequilenin, 17β-dihydroequilin, 17β-dihydroequilenin, 17β-estradiol and δ 8,9 dehydroestrone. MPA is a wh Aqra d-dokument sħiħ